2seventy bio, Inc. logo

2seventy bio, Inc.

NASDAQ:TSVT

Overview | Financials
Company Name 2seventy bio, Inc.
Symbol TSVT
Currency USD
Price 4.4
Market Cap 226,590,892
Dividend Yield 0%
52-week-range 1.535 - 6.4
Industry Biotechnology
Sector Healthcare
CEO Mr. Nick Leschly
Website https://www.2seventybio.com

An error occurred while fetching data.

About 2seventy bio, Inc.

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has

Related Stocks

Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc.

NAUT

2.61 USD

Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc.

KPTI

0.903 USD

Immatics N.V. logo

Immatics N.V.

IMTX

9.33 USD

Atara Biotherapeutics, Inc. logo

Atara Biotherapeutics, Inc.

ATRA

9.71 USD

Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc.

ARCT

18 USD

Cara Therapeutics, Inc. logo

Cara Therapeutics, Inc.

CARA

0.297 USD

Immunovant, Inc. logo

Immunovant, Inc.

IMVT

29.39 USD

908 Devices Inc. logo

908 Devices Inc.

MASS

3.46 USD

Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

VERA

43.82 USD

Financials

Numbers are in millions USD

Numbers are in millions USD